SOPH — Sophia Genetics SA Income Statement
0.000.00%
Last trade - 00:00- $336.84m
- $329.57m
- $77.27m
Annual income statement for Sophia Genetics SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 40.5 | 47.6 | 62.4 | 65.2 | 77.3 |
| Cost of Revenue | |||||
| Gross Profit | 25.2 | 31.3 | 42.9 | 43.9 | 52.1 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 112 | 135 | 137 | 132 | 148 |
| Operating Profit | -71.5 | -87.8 | -74.8 | -66.6 | -70.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -73.5 | -87.6 | -78.5 | -61.3 | -77.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -73.7 | -87.4 | -79 | -62.5 | -79 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -73.7 | -87.4 | -79 | -62.5 | -79 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -73.7 | -87.4 | -79 | -62.5 | -79 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.33 | -1.36 | -1.22 | -0.946 | -1.14 |